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Abstract: 
Objective:  To determine the diagnostic accuracy of point urinary albumin to creatinine ratio at 20+0 and 28+0 
weeks of gestation for predicting the possibility of developing pre-eclampsia, late in pregnancy. 
Study Design: A prospective cross sectional study. 
Place and Duration of Study: Gynecology Outpatients Department of Nishtar Hospital, Multan from January 
10, 2018 to January 10, 2019. 
Methodology: Age, weight, gravidity and Body Mass index was documented for total 250 patients included for 
study. Patients were divided on the basis of development of pre-eclampsia and their mean Albumin to creatinine 
ratio was compared by applying Student’s t-test considering p≤0.05 statistically significant. Test positive and 
test negative patients were noted. The association of urinary albumin to creatinine ratio with pre-eclampsia was 
calculated. SPSS v.23 software was used to analyze the data. 
Results: Mean urinary albumin to creatinine ratio was 22.77±12.42 mg/mmol in normotensive women and 
46.87±15.13 mg/mmol in pre-eclamptic women which was significantly higher in pre-eclamptic patients 
(p<0.001). The sensitivity of point urinary albumin to creatinine ratio at a cutoff value of 35.5mg/mmol is 
73.91%; the specificity is 91.56%; the positive predictive value (PPV) is 72.34%; and negative predictive is 
92.16%.  
Conclusion: Our study concluded that solitary point urinary albumin creatinine ratio values equal to or higher 
than 35.5mg/mmol, when quantified early during the second trimester had a higher specificity than the 
sensitivity and it can be safely used to rule out the possibility of developing pre-eclampsia, late in pregnancy. 
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Introduction:  
In pregnancy, pre-eclampsia is one of the major health issues 1. According to an estimate, 3-8% percent of all the 
pregnancies are complicated and result in a significant rise in perinatal maternal morbidity and mortality 2. It is 
the 2nd highest reason of maternal death, blamable for 11.1–17.4% deaths related to pregnancy 3. Pre-eclampsia 
is described as a minimum blood pressure of 140/90 mmHg documented on at least two discrete times, 
minimum of four hours apart, concomitant with at least 300mg of protein in a twenty four hours urine collection 
which occurs de novo after twentieth gestational week in a previously normotensive woman and it resolves fully 
after sixth week in postpartum period 4, 9. Pre-eclampsia can occur in a patient who is suffering from prolonged 
hypertension before the pregnancy, as well. Abnormal immunological interactions, genetic predilection, 
endothelial injury and dysfunction are believed to play a noteworthy part in its occurrence but the precise cause 
is not known, so far 5. Primary pregnancy, multi-parity, previous history of pre-eclampsia, body mass index 
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≥35kg/m2, familial history of pre-eclampsia, old age i.e. 40 years or above and multiple pregnancy are some of 
the danger factors for the development of pre-eclampsia 6, 10. Certain basic medical disorders for example 
chronic hypertension, chronic kidney disease, diabetes mellitus and anti-phospholipid antibodies syndrome are 
also thought to intensify the possibility of pre-eclampsia 10. 
Knowledge about the physiology and pathology of pre-eclampsia is defective. Genetic predilection is a key part 
player as a threefold to fourfold increase in the chances of pre-eclampsia in first degree relative of pre-eclamptic 
patient. The suggested process of pre-eclampsia begins with inadequate incursion, of maternal vascular bed, by 
trophoblastic cells due to any anomalous immunological reaction 7, 8, 9 which results in hypo-perfusion of 
placenta and leads to wide-ranging maternal endothelial dysfunction as well as increased vascular permeability. 
In normal pregnancy, there is peripheral vasodilation but in pre-eclampsia, there is occurrence of 
vasoconstriction which leads to increase in intra-vascular pressure which together with increased vascular 
permeability results in generalized body edema. Glomeruloendotheliosis is a condition which arises in kidneys 
and is rather specific for pre-eclampsia 9. There is concomitant impairment of glomerular filtration system and 
intermediate size proteins are lost in urine e.g. albumin and transferrin etc. 
A fair number of pregnancies are complicated by pre-eclampsia. There is necessity to define some screening 
methods to expect the occurrence pre-eclampsia to reduce the risk of perinatal maternal morbidity and mortality 
along with fetal problems. This can support to monitor and develop the quality of medical services in time afore 
pre-eclampsia arises and evolves into eclampsia 10, 11. Beneﬁt of the prophylactic administration of aspirin 12, 
heparin and calcium in high-risk patients 13 has been supported by some evidence. A few studies have been 
performed to define some sort of screening method to predict the risk of pre-eclampsia but outcomes have not 
been satisfactory, so far. Persistent micro albuminuria is indicative of huge possibility of impairment of the 
ﬁltration capability of the glomeruli of the kidney, and it is of great importance as a likely forecaster of pre-
eclampsia in pregnancy. Current study was done to analyze the usefulness of spot urinary albumin to creatinine 
ratio during early pregnancy, in asymptomatic pregnant women, to determine the likelihood of threat of pre-
eclampsia. 
 
Material and methodology: 
This is a prospective cross sectional study conducted from January 10, 2018 to January 10, 2019. The data was 
collected in Gynecology Outpatients Department of Nishtar Hospital, Multan, after obtaining ethical approval 
from the hospital ethical committee. The pregnant women patients who presented to the gynecology outdoor 
with singleton pregnancies at gestational age of 20 to 28 weeks were chosen using non probability consecutive 
sampling technique. Only those patients who were above eighteen years of age and had no proteinuria on 
dipstick test at the time of presentation were included in the study. A total of 250 patients were selected and 
informed consent was obtained from all of them, on written forms. Fifty patients could not follow up, mostly 
because of being from distant residential areas. All the patients were properly examined after history taking. 
Age, weight, gravidity, Body Mass index was documented. Risk factors of pre-eclampsia were ruled out. A point 
midstream urinary sample was gathered for the analysis. Albumin level was estimated using immune-
turbidimetric microalbumin method. Modified Jaffe’s technique in ERBA XL640 was used to estimate 
creatinine. Commercially available reagents were used.  All the patients were followed up till the time of 
delivery. Blood pressure was measured and the patients were assessed for the occurrence of signs and symptoms 
of pre-eclampsia for example edema, epigastric pain, nausea, vomiting, visual disturbances and altered urine 
output, at the time of each visit. A minimum blood pressure of 140/90 mmHg along with proteinuria is the 
definition of pre-eclampsia. As in our reference study conducted by Mishra VV et al. 14, 35.5mg/mmol was taken 
as cutoff value for Albumin to creatinine ratio. The values for Albumin to creatinine ratio was considered test-
positive if they were equal to or more than 35.5mg/mmol. The values below this level were considered test-
negative. Patients who did not consent or had multiple pregnancy, proteinuria at dip-stick, hematuria, chronic 
hypertension, acute renal failure, chronic kidney disease, current urinary tract infection, and/or diabetes mellitus 
were excluded from our study. 
All the data was collected by the researcher himself on a preformed Performa. Patients were divided on the basis 
of development of pre-eclampsia and their mean Albumin to creatinine ratio was compared by applying 
Student’s t-test, considering p≤0.05 statistically significant. Test positive and test negative patients were noted. 
The association of Albumin to creatinine ratio with pre-eclampsia was calculated. SPSS v.23 software was used 
to analyze the data. 
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Results: 
We enrolled 200 patients in our study. The mean age of all the patients was 27.50±5.78 years and mean body 
mass index was 28.63±5.03 kg/m2. Ninety three (46.5%) patients were primigravida and one hundred and seven 
(53.5%) patients were multigravida. Mean systolic blood pressure in the normotensive patients and pre-eclamptic 
patients was 115.35±4.78 mmHg and 143.27±3.38 mmHg, respectively. Mean diastolic blood pressure in the 
normotensive patients and pre-eclamptic patients was 81.78±3.37 mmHg and 95.48±2.65 mmHg, respectively.  
Mean urinary albumin to creatinine ratio was 22.77±12.42 mg/mmol in normotensive women and 46.87±15.13 
mg/mmol in pre-eclamptic women. This value was significantly higher in pre-eclamptic patients (p<0.001). 
According to our reference study 14, the cutoff value for urinary albumin to creatinine ratio was taken as 35.5 
mg/mmol.  (Table-I) 
Over all, the test was positive in forty seven (23.5%) patients and negative in the remaining one hundred and 
fifty three (76.5%) patients (Table-II).Table-III represents the association of albumin to creatinine ratio and pre-
eclampsia. This shows that out of total forty seven (23.5%) test-positive patients, thirty four (17%) developed 
pre-eclampsia in later stages of pregnancy and thirteen (6.5%) stayed normotensive. In test-negative patients, 12 
(6%) developed pre-eclampsia in later stages of pregnancy, while 141 (70.5%) stayed normotensive. The 
sensitivity of point urinary albumin to creatinine ratio at a cutoff value of 35.5mg/mmol is 73.91%; the 
specificity is 91.56%; the positive predictive value (PPV) is 72.34%; and negative predictive is 92.16%. 
 
Table-I 
Comparison of urinary Albumin Creatinine Ratio (ACR) between normotensive and preeclamptic 
patients 
ACR (mg/mmol) Normotensive (n=154) Pre-eclamptic (n=46) 
Mean ± S.D 22.77±12.42 46.87±15.13 
Range 3.90-47.88 19.80-88.78 
Median 24 47 
p-value <0.001 
P<0.001= statistically significant. 
 
Table-II 
Distribution of women according to the positivity of the test 
Test Used Test Positive Test Negative Total 
ACR (mg/mmol) 47 (23.5) 153 (76.5) 200 (100) 
Data are presented as Number (percentage); ACR= Albumin Creatinine Ratio. 
 
Table-III 
Association of Albumin Creatinine Ratio with pre-eclampsia 
Urinary ACR Normotensive Pre-eclamptic Total 
Test Positive 13 (6.5) 34 (17) 47 (23.5) 
Test negative 141 (70.5) 12 (6) 153 (76.5) 
Total 154 (77) 46 (23) 200 (100) 
Data are presented as Number (percentage); ACR= Albumin Creatinine Ratio. 
 
Discussion: 
We witnessed in our study that the many of the patients who had high albumin to creatinine ratio, observed while 
they were asymptomatic, developed pre-eclampsia; whereas most of those who were test-negative, did not. This 
test had higher specificity and negative predictive values as compared with the sensitivity and positive predictive 
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values.  Spot urinary albumin creatinine during 2nd trimester of pregnancy is a better tool to rule out the risk of 
pre-eclampsia. Having a small dissimilarity with our results, according to Mishra VV 14 et al, this test had a 
higher specificity as well as sensitivity and predicted pre-eclampsia with sensitivity of 87.5% and speciﬁcity of 
96.30%, long before the development of clinical signs and symptoms. They concluded that the test was sufficient 
enough to predict the possibility of pre-eclampsia. Although their inference was comparable with the ones 
presented by Baweja S. et al. 15 (83.3% sensitivity) and Fatema K et al. 16 (80% sensitivity), but the study 
consisted of a very small sample size. 
A arbitrary urinary protein to creatinine ratio is equally good as the protein content in twenty four hour collection 
of urine; and it is good enough to screen the patients at risk of pre-eclampsia for significant proteinuria, prior to 
development of clinical manifestation 17. Nisell H et al. 18 stated that a single sample albumin to creatinine ratio 
was no different from 24 hours urine collection, rather 24 hour collection of the urine is tiring for both the patient 
as well as the handling staff. Similar study was conducted by Cade TJ et al. 19 and they came to the conclusion 
that the protein creatinine ratio, at cutoff point 30mg/mmol, was considerably effective to clear the at-risk-
patients of significant proteinuria. Owing to the effectiveness of random urinary protein creatinine ratio, 24-hour 
urinary collection is seldom recommended. Singh R et al. 20 studied one hundred and forty four normotensive 
pregnant women in their twenty fourth to twenty eighth week of gestation. They found out that the 
microalbuminuria in second trimester was highly linked with development of pre-eclampsia, late in pregnancy, 
apart from its association with low birth weight babies and preterm delivery. 
Poon LC et al. 21 conducted a study on a large group of pregnant women between their 11th and 13+6 weeks of 
gestation. Their results were in contradiction with ours. They found positive protein urea in 55% of the 
normotensive patients and 75% of the pre-eclamptic patients. The protein to creatinine ratio did not give any 
fruitful results in the estimation of the probability of pre-eclampsia. The reason behind these results might be that 
the patients were observed too early, much before the age of viability of the fetus. 
 
Conclusion: 
Our study concluded that single point urinary albumin creatinine ratio values of equal to or higher than 
35.5mg/mmol, when quantified early during the second trimester, were good enough to expect pre-eclampsia 
before the onset of clinical signs, having 73.91% sensitivity and 91.56% specificity. Therefore it can be safely 
said that a positive test can expect the incidence of pre-eclampsia to a great extent, but a negative test rules out 
this possibility to a much greater extent.  
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